Results 231 to 240 of about 648,624 (244)
Some of the next articles are maybe not open access.
American Heart Journal, 1994
The intranasal administration of drugs has long been used for the topical treatment of various nasal disorders. Many features of the intranasal mucosa also make it useful for delivery of systemically active agents. It has been shown that intranasal drug administration can provide plasma drug levels similar to those observed with comparable doses of ...
William H. Frishman +2 more
openaire +2 more sources
The intranasal administration of drugs has long been used for the topical treatment of various nasal disorders. Many features of the intranasal mucosa also make it useful for delivery of systemically active agents. It has been shown that intranasal drug administration can provide plasma drug levels similar to those observed with comparable doses of ...
William H. Frishman +2 more
openaire +2 more sources
Chapter 7. Cardiovascular Agents
1975Publisher Summary This chapter discusses potentially important non-diuretic hypotensive, antiarrythmic and antianginal agents. The oldest known hypotensives is sodium nitroprusside. It is indicated for rapid reduction of blood pressure in hypertensive crisis and is given only as an intravenous infusion because its effect is evanescent.
openaire +2 more sources
Antihypertensive Agents and Cardiovascular Risk
1992Controlled trials have made it clear that drug treatment reduces the morbidity of hypertensive disease, in severe (51) and in mild to moderate hypertension (2,15,19,33,37,46,50,52). There was a clear reduction in the frequency of stroke, heart failure, hypertensive encephalopathy, renal failure, and dissecting aneurysms but was ineffective in reducing ...
openaire +2 more sources
Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery, 2006Basic and clinical investigation into many of the diverse aspects of cardiovascular drug discovery employs varied approaches aimed at determining physiologic and pathophysiologic efficacy of candidate agents for therapeutic utility with the ultimate hope of identifying those agents capable of exerting salutary influence upon cardiac and vascular ...
openaire +3 more sources
3 4-Quinolones as Potential Cardiovascular Agents
1995Publisher Summary This chapter focuses on 4-Quinolones as potential cardiovascular agents. Cardiovascular diseases continue to be the focus of considerable attention from the pharmaceutical industry. Prevalence of the disease is high in Western society and, despite publicity surrounding healthier lifestyles, is likely to continue to be a problem. The
Davies Roy Victor, Yates David Bryan
openaire +3 more sources
Cardiovascular Effects of Inhalant Anesthetic Agents
1985Halothane and methoxyflurane have been the most commonly used halogenated inhalation anesthetic agents for general anesthesia in veterinary medicine. The use of other agents such as isoflurane, enflurane and desflurane are becoming more common Methoxyflurane is used extensively in veterinary practice, primarily for cost considerations, while it is used
openaire +2 more sources
Compatibility of Argatroban with Selected Cardiovascular Agents
American Journal of Health-System Pharmacy, 2004Marcia E. Honisko +4 more
openaire +3 more sources